In an interim analysis of the phase II DASFREE trial, 63% of patients who stopped taking dasatinib (Sprycel) were still without loss of major molecular response (MMR) a year after discontinuing medication, said Neil Shah, MD, PhD, of the University of California San Francisco, and colleagues.
"These data build upon the growing body of evidence supporting the feasibility of TFR in patients with CML-CP and demonstrate that with frequent monitoring of BCR-ABL1, patients treated with dasatinib in the first and second line can successfully discontinue treatment. Longer-term follow-up is ongoing," the authors concluded.
... probably would have had higher rates of success if they followed my formula as recommended by Trey:
1. Omega 3- (krill oil)
2. Cinnamon with chromium (sugar control)
3. Zinc / selenium
4. Magnesium (at least 400 mg sometime 600-800 per day)
5. Only grass fed beef.
6. Curcumin (lots of it)
7. Garlic (4 grams per day or food)
8. Nuts (almonds)
I so look forward to my next cessation trial. Maybe as soon as January!